- Director, Health Policy
- In Health Policy Department
- Reports to VP, Health Policy & Research
- Full-time, Exempt Position
Biotechnology Innovation Organization (BIO) is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and in 30+ countries. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial, and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
The Director, Health Policy, will advance BIO’s policies in value-based healthcare, including pharmaceutical value-based pricing, assessment, and payment reforms. The Director leads, conducts and manages research and analysis related to clinical and economic value assessment, payment reform, scoring of legislative proposals on drug pricing, benefit design, and patient access. The Director also leads the development of quick turn-around economic analysis to support BIO’s advocacy at the Federal and State level. The Director will combine their policy analysis and research acumen with strong communication skills to advance BIO’s vision for ensuring equity and access with regard to innovative medicines.
- Conceive, oversee, conduct, and/or analyze studies to demonstrate the value of BIO members’ innovative treatments and therapies, as well as to support advocacy by evaluating the impact of policy proposals on biotechnology innovation.
- Lead the development and implementation of a policy research agenda in support of annual strategic goals identified by BIO’s Health Section Governing Board.
- Lead BIO’s efforts on value frameworks and comparative effectiveness research; serve as BIO’s chief representative with IVI, ICER and other critical organizations by advocating for policies that account for and demonstrate the value innovative biopharmaceuticals bring to patients
- Lead efforts to conceptualize and prepare rapid-response research, economic analysis regarding the value of biotechnology products, including the impact of Federal or State legislative or regulatory proposals. Lead efforts to conduct economic analysis of proposed policies by market segment, including impacts on commercial, Medicare, and Medicaid sectors.
- Lead the development of a network of pharmacoeconomics, healthcare economics, and outcomes research individuals within BIO’s membership and externally, as well as at federal agencies and related entities (e.g., CMS, GAO, OIG, MedPAC), to assist in identifying and making recommendations on economic trends and policies affecting the industry, to develop BIO’s research agenda, and to advance BIO’s policy priorities.
- Manage commissioning and drafting of research papers by BIO consultants on key research areas at both the state and federal level.
- Analyze legislative and regulatory proposals to determine their impact on access to innovative therapies
- Supervise policy and analysis of junior level staff, including the analysis and critique of external research reports.
- Represent BIO in senior-level meetings internally and externally.
- Other duties/projects as assigned.
Required Background, EDUCATION, and skills
- Graduate degree in economics, public policy, etc., with experience managing policy research initiatives.
- Prior experience working in a legislative policy position or regulatory department for a trade association, appropriate Federal agency, or biotechnology company strongly preferred.
- Minimum 8+ years of relevant work experience
- Strong academic training in health policy analysis, Federal budgeting or an economic field.
- Superior analytic and communication skills to quickly distill complex information into succinct and accessible materials for use by BIO advocacy teams.
- Experience creating policy research, including projects with a quick turn around, to help equip advocacy teams to engage in a substantive, data driven manner on key legislative/regulatory issues.
- Demonstrated analytical skills, plus an ability to communicate technical information in an effective, easily understandable way.
- Background in health economics/reimbursement and Congressional budget scoring is extremely valuable.
- Experience with or knowledge of the biotechnology or pharmaceutical industry, and the business, legal and policy environment it operates in, is an advantage.
- Strong knowledge of legislative and regulatory processes.
- Ability to work collaboratively with colleagues, balanced by independence and initiative.
- The ideal candidate should be able to effectively translate highly technical quantitative research and analysis into actionable and easy to digest messaging for use in BIO advocacy materials.
- Knowledge of the legislative and regulatory environments of federal health care programs such as Medicare, Medicaid, CHIP, ACA marketplace, 340B, etc. are highly desirable.
Candidates should be aware that BIO currently maintains a policy requiring all US-based employees to be fully vaccinated against COVID-19 and receive a booster shot once eligible. Newly hired employees must be vaccinated and boosted prior to their employment start date BIO is an equal opportunity employer and will provide a reasonable accommodation to those unable to be vaccinated or receive a booster where it is not an undue hardship to the company to do so as provided under federal, state, and local law.